Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 10
Submit an article Journal homepage
83
Views
11
CrossRef citations to date
0
Altmetric
Letters to the Editor

Efficacy of rituximab in combination with steroids in refractory chronic lymphocytic leukemia

J. P. Quinn Department of Haematology, University College London Hospitals, London, UKCorrespondence[email protected]
,
S. Mohamedbhai Department of Haematology, University College London Hospitals, London, UK
,
K. Chipperfield Department of Haematology, University College London Hospitals, London, UK
,
M. Treacy Department of Haematology, Chase Farm Hospital, London, UK
,
S. D'Sa Department of Haematology, University College London Hospitals, London, UK
&
A. C. Nathwani Department of Haematology, University College London Hospitals, London, UK
Pages 1995-1998 | Received 20 May 2008, Accepted 11 Jul 2008, Published online: 01 Jul 2009

References

  • Keating M J, Flinn I, Jain V, et al. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood 2002; 99: 3554–3561
  • Bowen D A, Call T G, et al. Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features. Leuk Lymphoma 2007; 48: 2412–2417
  • Thornton P D, Matutes E, et al. High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities. Ann Hematol 2003; 82: 759–765
  • Thornton P D, Hamblin M, et al. High dose methylprednisolone in refractory chronic lymphocytic leukaemia. Leuk Lymphoma 1999; 4: 167–170
  • Cheson B D, Bennett J M, et al. National cancer institute sponsored working group guidelines for chronic lymphocytic leukaemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997
  • Dungarwalla M, Evans S O, et al. High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy. Haematologica 2008; 93: 475–476
  • Keating M J, O'Brien S, Albitar M, et al. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 4079–4088
  • Byrd J C, Rai K, et al. Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011. Blood 2005; 105: 49–53
  • Rose A L, Smith B E, Maloney D G. Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects. Blood 2002; 100: 1765–1773
  • Tam C S, Otero-Palacios J, et al. Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients. Br J Haematol 2008; 141: 36–40
  • Klepfish A, Schattner A, Ghoti H, et al. Addition of fresh frozen plasma as a source of complement to rituximab in advanced chronic lymphocytic leukaemia. Lancet Oncol 2007; 8: 361–362

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.